TrialSignal transduction and targeted therapy2026

Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, open-label phase 2 study.

Zhe Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.